Rosalind Advisors, Inc. - Q1 2023 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q1 2023
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MYOMO INC-NEW3Q2 20247.9%
DELCATH SYSTEMS, INC.3Q2 202411.9%
XERIS BIOPHARMA HLDGS INC3Q2 20246.9%
MEDIWOUND LTD-NEW3Q2 20246.5%
OPTINOSE INC3Q2 20246.2%
LYRA THERAPEUTICS INC3Q2 20248.2%
COMPASS PATHWAYS PLC ADR3Q2 20245.8%
VIRIDIAN THERAPEUTICS INC3Q2 20246.5%
CELLECTAR BIOSCIENCES-NEW3Q2 20245.2%
PROFOUND MEDICAL CORP-NEW3Q2 20244.3%

View Rosalind Advisors, Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Rosalind Advisors, Inc. Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Biofrontera Inc.May 29, 2024504,2619.9%
KIORA PHARMACEUTICALS INCMay 29, 20242,300,0009.9%
OptiNose, Inc.May 29, 20247,547,1487.8%
DELCATH SYSTEMS, INC.May 17, 20242,763,4689.9%
SPRUCE BIOSCIENCES, INC.April 25, 20241,508,4193.7%
PolyPid Ltd.March 01, 2024415,80010.0%
GUIDED THERAPEUTICS INCSold outFebruary 20, 202400.0%
Sientra, Inc.Sold outFebruary 20, 202400.0%
MYOMO, INC.August 28, 20232,611,4189.8%
PhaseBio Pharmaceuticals IncFebruary 14, 2022707,4671.5%

View Rosalind Advisors, Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-08-14
SC 13G/A2024-08-14
13F-HR2024-07-12
SC 13G/A2024-07-11
SC 13G/A2024-07-11
SC 13G/A2024-07-11
SC 13G/A2024-07-11
SC 13G/A2024-07-11
SC 13G/A2024-07-11
SC 13G/A2024-05-29

View Rosalind Advisors, Inc.'s complete filings history.

All filings

View complete filings history.

Compare quarters

Export Rosalind Advisors, Inc.'s holdings

CSVXLS